News Ticker

[ March 23, 2023 ] Scientist (FT) – BioSpyder Technologies, Inc. – Carlsbad, CA San Diego Biotech Jobs
[ March 22, 2023 ] Ionis accounces FDA advisory committee voted unanimously for a potential accelerated approval of tofersen for SOD1-ALS News
[ March 22, 2023 ] Director/Senior Director, Human Resources – Recludix Pharma – San Diego, CA San Diego Biotech Jobs
[ March 22, 2023 ] Principal Scientist, Protein Engineering – Neurocrine Bioscience – San Diego, CA San Diego Biotech Jobs
[ March 22, 2023 ] Sr. Research Scientist I, Formulation Process Development – Gilead Sciences – Oceanside, CA San Diego Biotech Jobs

Imprimis Pharmaceuticals Receives Institutional Review Board (IRB) Approval for Its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013

July 22, 2013 sandiegobiotech Uncategorized Comments Off

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, July 22, 2013 /PRNewswire/ — Imprimis Pharmaceuticals…

Copyright © 2022 Biotech Networks, LLC